NO137858C - Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner

Info

Publication number
NO137858C
NO137858C NO4652/73A NO465273A NO137858C NO 137858 C NO137858 C NO 137858C NO 4652/73 A NO4652/73 A NO 4652/73A NO 465273 A NO465273 A NO 465273A NO 137858 C NO137858 C NO 137858C
Authority
NO
Norway
Prior art keywords
indanons
preparation
therapeutically active
analogical procedure
analogical
Prior art date
Application number
NO4652/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO137858B (no
Inventor
Philip Dietrich Hammen
George Mclean Milne
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO137858B publication Critical patent/NO137858B/no
Publication of NO137858C publication Critical patent/NO137858C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C225/18Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings the carbon skeleton containing also rings other than six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO4652/73A 1972-12-06 1973-12-05 Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner NO137858C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/312,693 US4022836A (en) 1972-12-06 1972-12-06 2-Aminomethyleneindanone analgesic agents

Publications (2)

Publication Number Publication Date
NO137858B NO137858B (no) 1978-01-30
NO137858C true NO137858C (no) 1978-05-10

Family

ID=23212586

Family Applications (1)

Application Number Title Priority Date Filing Date
NO4652/73A NO137858C (no) 1972-12-06 1973-12-05 Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner

Country Status (20)

Country Link
US (2) US4022836A (pt)
JP (1) JPS5542066B2 (pt)
AR (1) AR207946A1 (pt)
AT (1) AT326646B (pt)
BE (1) BE808275A (pt)
CA (1) CA1002068A (pt)
CH (1) CH584677A5 (pt)
DE (1) DE2360096C2 (pt)
DK (1) DK139575B (pt)
ES (1) ES421167A1 (pt)
FR (1) FR2209565B1 (pt)
GB (1) GB1448026A (pt)
IE (1) IE38553B1 (pt)
IL (1) IL43722A (pt)
LU (1) LU68950A1 (pt)
NL (1) NL172057C (pt)
NO (1) NO137858C (pt)
PH (1) PH10690A (pt)
SE (1) SE405851B (pt)
ZA (1) ZA739052B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117012A (en) * 1972-12-06 1978-09-26 Pfizer Inc. 2-aminomethyleneindanone analgesic agents
US4164514A (en) * 1972-12-06 1979-08-14 Pfizer Inc. 2-Aminomethyleneindanone analgesic agents
US4334085A (en) * 1978-09-14 1982-06-08 Standard Oil Company (Indiana) Transamination process for Mannich products
NZ209534A (en) * 1983-09-30 1987-01-23 Surgikos Inc Antimicrobial fabric for surgical drape
US6369289B1 (en) 2000-07-07 2002-04-09 Tyco Healthcare Group Lp Method and manufacture of a wound dressing for covering an open wound
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
AU2006239221C1 (en) 2005-04-28 2012-08-16 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3454565A (en) * 1966-10-05 1969-07-08 American Cyanamid Co Novel indanones

Also Published As

Publication number Publication date
BE808275A (fr) 1974-06-06
IE38553B1 (en) 1978-04-12
FR2209565B1 (pt) 1977-04-08
US4022836A (en) 1977-05-10
AU6302373A (en) 1975-05-29
CA1002068A (en) 1976-12-21
DE2360096C2 (de) 1982-07-01
FR2209565A1 (pt) 1974-07-05
SE405851B (sv) 1979-01-08
ES421167A1 (es) 1976-04-01
SE7316447L (pt) 1974-06-07
IE38553L (en) 1974-06-06
NL172057C (nl) 1983-07-01
US4064272A (en) 1977-12-20
AT326646B (de) 1975-12-29
PH10690A (en) 1977-08-10
DK139575B (da) 1979-03-12
LU68950A1 (pt) 1974-07-05
NL7316663A (pt) 1974-06-10
IL43722A0 (en) 1974-03-14
NL172057B (nl) 1983-02-01
DK139575C (pt) 1979-08-27
JPS5542066B2 (pt) 1980-10-28
JPS4986352A (pt) 1974-08-19
ATA1013873A (de) 1975-03-15
AR207946A1 (es) 1976-11-22
CH584677A5 (pt) 1977-02-15
NO137858B (no) 1978-01-30
DE2360096A1 (de) 1974-07-04
GB1448026A (en) 1976-09-02
ZA739052B (en) 1974-10-30
IL43722A (en) 1976-03-31

Similar Documents

Publication Publication Date Title
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO139560C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
NO793013L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater
NO781312L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-merkaptotiadiazol- eller merkaptotetrazol-cefalosporiner
NO138335C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
NO136837C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pleuromutiliner
NO137941C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt tri-p-toluensulfonat av s-adenosyl-l-methionin
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO138565C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO142033C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive isopropylamino-3-fenoksypropanoler
NO139127C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylalkylaminer
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO140670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO139088C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner
NO138063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater
NO137151C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive ortiotropin-peptider
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO138026C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner
NO138025C (no) Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler
NO138251C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer
NO139050C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater
NO140299C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner
NO137727C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-hydroksy-3-metyltriazener